Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Müller-Schweinitzer

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Cardiovascular Drugs and Therapy|December 1, 1990
Venoconstrictor responses to dihydroergocristine and dihydroergotamine: evidence for the involvement of 5-HT1 like receptorsE Müller-Schweinitzer
Research and Clinical Studies in Headache|January 1, 1978
Studies on the 5-HT receptor in vascular smooth muscleE Müller-Schweinitzer
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1980
In vitro studies on the duration of action of dihydroergotamineE Müller-Schweinitzer
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 1, 1989
Interaction of cyclosporine-A with the renin-angiotensin system in canine veinsE Müller-Schweinitzer
Cryobiology|February 1, 1994
Applications for cryopreserved blood vessels in pharmacological researchE Müller-Schweinitzer
Journal of Cardiovascular Pharmacology|July 1, 1986
Pizotifen, an antimigraine drug with venoconstrictor activity in vivoE Müller-Schweinitzer
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 25, 1976
Responsiveness of isolated canine cerebral and peripheral arteries to ergotamineE Müller-Schweinitzer
Cryobiology|August 1, 1994
Arterial smooth muscle function after prolonged exposure to a medium containing dimethyl sulfoxide (Me2SO) and storage at -196 degrees CE Müller-Schweinitzer
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 1, 1984
Alpha-adrenoceptors, 5-hydroxytryptamine receptors and the action of dihydroergotamine in human venous preparations obtained during saphenectomy procedures for varicose veinsE Müller-Schweinitzer
International Journal of Clinical Pharmacology, Therapy, and Toxicology|December 1, 1984
What is known about the action of dihydroergotamine on the vasculature in man?E Müller-Schweinitzer
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Cardiovascular Drugs and Therapy|December 1, 1990
Venoconstrictor responses to dihydroergocristine and dihydroergotamine: evidence for the involvement of 5-HT1 like receptorsE Müller-Schweinitzer
Research and Clinical Studies in Headache|January 1, 1978
Studies on the 5-HT receptor in vascular smooth muscleE Müller-Schweinitzer
International Journal of Clinical Pharmacology, Therapy, and Toxicology|January 1, 1980
In vitro studies on the duration of action of dihydroergotamineE Müller-Schweinitzer
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 1, 1989
Interaction of cyclosporine-A with the renin-angiotensin system in canine veinsE Müller-Schweinitzer
Cryobiology|February 1, 1994
Applications for cryopreserved blood vessels in pharmacological researchE Müller-Schweinitzer
Journal of Cardiovascular Pharmacology|July 1, 1986
Pizotifen, an antimigraine drug with venoconstrictor activity in vivoE Müller-Schweinitzer
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 25, 1976
Responsiveness of isolated canine cerebral and peripheral arteries to ergotamineE Müller-Schweinitzer
Cryobiology|August 1, 1994
Arterial smooth muscle function after prolonged exposure to a medium containing dimethyl sulfoxide (Me2SO) and storage at -196 degrees CE Müller-Schweinitzer
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 1, 1984
Alpha-adrenoceptors, 5-hydroxytryptamine receptors and the action of dihydroergotamine in human venous preparations obtained during saphenectomy procedures for varicose veinsE Müller-Schweinitzer
International Journal of Clinical Pharmacology, Therapy, and Toxicology|December 1, 1984
What is known about the action of dihydroergotamine on the vasculature in man?E Müller-Schweinitzer
Pageof 6